Hydroxyethyl starch Disease Interactions
There are 5 disease interactions with hydroxyethyl starch.
Hydroxyethyl starch (applies to hydroxyethyl starch) coagulation disorders
Major Potential Hazard, Moderate plausibility. Applicable conditions: Coagulation Defect, Intracranial Hemorrhage
Do not use hydroxyethyl starch products with preexisting coagulation or bleeding disorders, including those patients with intracranial bleeding.
Hydroxyethyl starch (applies to hydroxyethyl starch) liver dysfunction
Major Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Do not use hydroxyethyl starch products in patients with severe liver disease.
Hydroxyethyl starch (applies to hydroxyethyl starch) renal disease
Major Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction
Do not use hydroxyethyl starch products in patients with renal failure with oliguria or anuria not related to hypovolemia, including those patients receiving dialysis treatment.
Hydroxyethyl starch (applies to hydroxyethyl starch) sepsis
Major Potential Hazard, Moderate plausibility.
Do not use hydroxyethyl starch products in critically ill adult patients, including patients with sepsis, due to increased risk of mortality and renal replacement therapy.
Hydroxyethyl starch (applies to hydroxyethyl starch) volume overload
Major Potential Hazard, Moderate plausibility. Applicable conditions: Hypernatremia
Do not use hydroxyethyl starch products with severe hypernatremia or severe hyperchloremia and in clinical conditions with volume overload.
Switch to professional interaction data
More about hydroxyethyl starch
- hydroxyethyl starch consumer information
- Compare alternatives
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: plasma expanders
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Albuked
Albuked is used for burns, external, hypoproteinemia, pancreatitis, peritonitis, postoperative ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Albuked 25
Albuked 25 is used for burns, external, hypoproteinemia, pancreatitis, peritonitis, postoperative ...
Albuked 5
Albuked 5 is used for burns, external, hypoproteinemia, pancreatitis, peritonitis, postoperative ...
Albuminar-25
Albuminar-25 is used for burns, external, hypoproteinemia, pancreatitis, peritonitis, postoperative ...
Alburx
Alburx is used for burns, external, hypoproteinemia, pancreatitis, peritonitis, postoperative ...
Albutein
Albutein is used for burns, external, hypoproteinemia, pancreatitis, peritonitis, postoperative ...
Buminate
Buminate is used for burns, external, hypoproteinemia, pancreatitis, peritonitis, postoperative ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.